Little is known about the association between plasma adiponectin levels and nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.